Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Parliament Passes Updated Cosmetics Directive For All 27 European States

Executive Summary

The European Parliament has modernized cosmetics oversight by replacing the national laws of its 27 member-countries with a single regulation
Advertisement

Related Content

EC's Delayed Nano Inventory Reflects Notification Errors, Definitional Challenges
EU Ushers In New Cosmetics Regs; Experts Offer Perspective
ASEAN Can Be Launching Pad For Cosmetics Firms Eyeing Eastern Markets
Patent Filings Up As Industry Continues Investing In Nanotech Research
New EU Cosmetics Regs Expected Before Year-End; Focus Is Accountability
Industry Investment Needed Toward Alternative Tests For Thornier Endpoints
Euro Consumer Group Cheers Directive’s Nanotech Rules, But Notes Loopholes
TSCA, “Badly In Need Of Reform,” Comes Under Congressional Scrutiny
European Parliament Adds Nanotech Regs To Updated Cosmetics Directive
European Parliament Adds Nanotech Regs To Updated Cosmetics Directive
Advertisement
UsernamePublicRestriction

Register

RS016056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel